Noveris Health Sciences Inc. NVRS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 651.30K | 355.60K | 386.90K | 849.50K | 1.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 645.20K | 324.40K | 355.70K | -1.08M | 196.70K |
| Operating Income | -645.20K | -324.40K | -355.70K | 1.08M | -196.70K |
| Income Before Tax | 1.17M | 1.15M | 2.10M | 1.62M | 109.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.17 | 1.15 | 2.10 | 1.62 | 0.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.17M | 1.15M | 2.10M | 1.62M | 109.10K |
| EBIT | -645.20K | -324.40K | -355.70K | 1.08M | -196.70K |
| EBITDA | -- | -- | -- | 1.44M | 239.30K |
| EPS Basic | 1.81 | 1.80 | 1.70 | 1.32 | 0.09 |
| Normalized Basic EPS | -0.17 | -0.21 | -0.34 | 0.35 | -0.41 |
| EPS Diluted | 1.81 | 1.80 | 1.70 | 1.32 | 0.09 |
| Normalized Diluted EPS | -0.17 | -0.21 | -0.34 | 0.35 | -0.41 |
| Average Basic Shares Outstanding | 76.89M | 19.58M | 4.94M | 4.94M | 4.94M |
| Average Diluted Shares Outstanding | 76.89M | 19.58M | 4.94M | 4.94M | 4.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |